Prothena Seeking to Develop Therapies to Block Underlying Cause of Parkinson’s Disease

As part of a new industry series, WuXi AppTec Communications asked Prothena’s CEO Gene Kinney to share his thoughts on Prothena’s research, its potential, and what new developments are on the horizon for Parkinson’s disease.

Continue to read the conversation.